Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03296475
Other study ID # 17/0344
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date January 9, 2018
Est. completion date December 1, 2021

Study information

Verified date May 2018
Source University College, London
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: A detailed study of the biomechanical changes before and after abdominal wall reconstruction (AWR) has not been performed. Changes in abdominal wall tension and intra-abdominal pressure have physiological consequences on respiratory and cardiology function. AWR surgeons currently do not know if they are applying too much tension when re-aligning the abdominal wall muscles during AWR. Too much tension is likely to cause respiratory and cardiac post-operative complications. The investigators propose to study the perioperative changes in abdominal biomechanics and cardiorespiratory physiology after AWR. In addition, investigators will also analyze the pre-operative patient CT scan to see if there any CT predictors of post-operative cardiorespiratory complications and hernia recurrence. The researchers hypothesize that there is a threshold value or force at which ventral hernias are repaired 'too tight' subjecting the patient to the increased risk of recurrence and cardiorespiratory complications.

Method: An in depth biomechanical and physiological study of 18-22 participants with midline ventral hernias will be carried out. Ventral hernias at least 5cm in width and only those in which primary fascial closure have been achieved will be included. Any operative technique used to achieve primary fascial closure will be included. Biomechanical and physiological measurements will be taken at five separate stages during the course of the patients' abdominal wall reconstruction. The final lung function tests, taken six weeks post op, will be compared to the patients' pre-operative tests. Meticulous attention will be paid to the study protocol making sure that in each patient the measurements are all taken at the same time and under the same conditions.

Discussion: This full biomechanical and physiological work up will enable AWR surgeons to assess when an AWR patient is subjected to too much biomechanical and physiological stress. The abdominal wall tension and strain will be measured to see if this predicts post complications and hernia recurrence.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 20
Est. completion date December 1, 2021
Est. primary completion date December 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with midline hernia defects. Only patients with one or more midline defect will be included. For our study, we will define a midline hernia as herniation through the linea alba and with the rectus muscles falling either side of the hernia. The pre-operative CT scan will be used to study the hernia morphology and to see whether the patient fulfills these criteria.

- Patients undergoing primary or incisional ventral hernia repair, without formation of or closure of a stoma.

- Patients with either a maximal ventral hernia axial width of greater than 5cm or a loss of domain of greater then 20%, as measured on their pre-operative CT or MRI scan. The loss of domain will be measured using the patients' preoperative CT or MRI scan following the method of Tanaka et al.

- Patients aged = 18 years old.

- Midline hernias closed in the midline with primary fascial closure with or without mesh augmentation. Any reconstruction technique can be used (e.g. anterior or posterior component separation) as long as primary fascial closure is achieved. The mesh may be placed in either the retro-rectus position (with or without a transverse abdominis release) or the onlay position.

- Participants who have a synthetic or bio-synthetic mesh implanted.

- Midline ventral hernias of VHWG grade 2 or 3. Clean and or Clean-contaminated wound classification.

- The participant is legally competent, has been informed of the nature, the scope and the relevance of the study, voluntarily agrees to take part and has duly signed the consent form.

Exclusion Criteria:

- Emergency/Redo surgery.

- Defects not in the midline. Patients with one or more defect not through the linea alba on the pre-operative CT scan.

- AWR for abdominal wall sarcoma, invasive intra-abdominal carcinoma or other malignant disease.

- Contaminated VHWG grade 4 hernias. Or Contaminated or Dirty wound according to the CDC wound classification system.

- Concomitant procedures such as bowel resection.

- The hernia requires a bridged repair.

- Individuals with co-morbid respiratory disease requiring oral corticosteroids or home oxygen therapy.

- Individuals who require the mesh to be placed in the intra-abdominal position.

- A patient with active peritonitis or an active mesh or subcutaneous infection.

- Individuals with a diagnosis of Crohn's disease.

- Individuals of American Society of Anesthesiology grade 4 or 5.

- Complete removal of an existing synthetic mesh (or biosynthetic mesh if not absorb) from a prior hernia repair in the same location is not possible.

- Participants with human immunodeficiency virus (HIV), known liver cirrhosis or alcohol abuse with a known relapse within 12 months.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Abdominal Wall Closure Force (N).
This measurement will be recorded for both the right and left anterior rectus sheath. We will measure this force at three anatomical points 1) at the level of the umbilicus and 2) at the halfway point between the pubic symphysis and the xiphisternum and 3) at the point of maximal hernia defect width.

Locations

Country Name City State
United Kingdom Univeristy College London London

Sponsors (2)

Lead Sponsor Collaborator
University College, London University College London Hospitals

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dynamic Lung Compliance (measured in ml/cmH2O) The primary outcome is the difference in Lung Compliance between stages 3 and 4 of the peri-operative protocol. i.e. we will measure the change in dynamic lung compliance before (after adhesiolysis) and after abdominal wall closure. We will measure this with a standard operative ventilator. Every patient will have a definitive airway (ET tube) fitted. Day 1. Both measurements will be taken on the participants first day of the study. (Study enrollment will take place on the day of the participants operation.
Secondary Perioperative changes in Total Lung Capacity (Litres) Total Lung Capacity (TLC) (Litres). TLC will be measured using spirometry before and after the patients AWR operation. TLC will be measured on Day 1 and at 6 weeks, 12 months and 3 years after the patients operation.
Secondary Perioperative changes in Force Expiratory Volume (Litres) Force Expiratory Volume over 1 second, FEV1 (Litres). FEV1 will be measured using spirometry before and after the patients AWR operation. FEV1 will be measured on Day 1 and at 6 weeks, 12 months and 3 years after the patients operation.
Secondary Perioperative changes in Tidal Volume (Litres) Tidal Volume, VT (Litres). VT will be measured using spirometry before and after the patients AWR operation. VT will be measured on Day 1 and at 6 weeks, 12 months and 3 years after the patients operation.
Secondary Perioperative changes in Residual Volume (Litres) Residual Volume, RV (Litres). RV will be measured using spirometry before and after the patients AWR operation. RV will be measured on Day 1 and at 6 weeks, 12 months and 3 years after the patients operation.
Secondary Perioperative changes in Peak Expiratory Flow (Litres/min) Peak Expiratory Flow, PEF (Litres/min). PEF will be measured using spirometry before and after the patients AWR operation. PEF will be measured on Day 1 and at 6 weeks, 12 months and 3 years after the patients operation.
Secondary Perioperative changes in Dynamic Lung Compliance (ml/cmH2O) Dynamic Lung Compliance, LC (ml/cmH2O). LC will be measured using spirometry before and after the patients AWR operation. LC will be measured on Day 1 and at 6 weeks, 12 months and 3 years after the patients operation.
Secondary Abdominal wall closure force before abdominal wall closure (Newtons) Measured in Newtons (N) with a Mecmesin Newton meter. After adhesiolysis (stage 3) and before abdominal wall closure. Day 1. These abdominal wall closure measurements will be taken during the participants operation on the first day of the study. i.e. after enrollment, which will take place on the day of their operation.
Secondary Abdominal wall strain index (no units) (this is a strain index, change in transverse length (cm) / original transverse length of abdominal wall (cm)) Calculated using the pre-operative CT or MRI and by recording the hernia defect width intra-operatively. Day 1. Defect width readings taken during the abdominal wall reconstruction operation
Secondary Ventral hernia recurrence Rate of ventral hernia recurrence at 1 year, defined by clinical examination and supplemented by cross-sectional imaging where there is diagnostic uncertainty. Recurrence will be defined using the European classification for ventral hernia recurrence. At 1 year after the patients operation.
Secondary Perioperative change in Intra-abdominal pressure (IAP) (mmHg) Intra-abdominal pressure IAP (mmHg) will be measured using a transducer probe inserted into the bevel of a urinary catheter. The bladder will be inflated with 50ml of normal saline solution, the catheter will be clamped off distal to the position of the transducer/bevel. The bag of normal saline will be lowered to the level of the bladder when the IAP readings are taken. IAP reading will be taken at stages 2, 3 and 4 of our protocol (ie after induction of anaesthetic, after adhesiolysis, and after abdominal wall closure). Day 1. Readings taken during the abdominal wall reconstruction operation
Secondary Perioperative change in cardiac output (CO) (L/min) Each participant will be fitted with an oesophageal doppler probe during their operation. This will measure the cardiac output. CO readings will be taken at stages 2, 3 and 4 of our protocol (ie after induction of anaesthetic, after adhesiolysis, and after abdominal wall closure). Day 1. Readings taken during the abdominal wall reconstruction operation
Secondary Perioperative change in stroke volume (SV) (L) Each participant will be fitted with an oesophageal doppler probe during their operation. This will measure the cardiac stroke volume. SV readings will be taken at stages 2, 3 and 4 of our protocol (ie after induction of anaesthetic, after adhesiolysis, and after abdominal wall closure). Day 1. Readings taken during the abdominal wall reconstruction operation
Secondary Perioperative change in positive-end expiratory pressure (PEEP) (cm/H2O) Positive-end expiratory pressure (PEEP) (cm/H2O) will be measured using the operative ventilator during the patient's operation. PEEP readings will be taken at stages 2, 3 and 4 of our protocol (ie after induction of anaesthetic, after adhesiolysis, and after abdominal wall closure). Day 1. Readings taken during the abdominal wall reconstruction operation
Secondary Perioperative change in fraction of inspired oxygen (fraction or as a per cent) Fraction of inspired oxygen (FiO2) will be measured using the operative ventilator during the patient's operation. FiO2 readings will be taken at stages 2, 3 and 4 of our protocol (ie after induction of anaesthetic, after adhesiolysis, and after abdominal wall closure). Day 1. Readings taken during the abdominal wall reconstruction operation
Secondary Perioperative physiological changes in partial pressure of oxygen (pO2) (kPA) Blood partial pressure of oxygen (pO2) (kPA) will be measured from arterial gas samples that will be taken from the patients arterial line during the operation.
pO2 readings will be taken at stages 2, 3 and 4 of our protocol (ie after induction of anaesthetic, after adhesiolysis, and after abdominal wall closure).
Day 1. Readings taken during the abdominal wall reconstruction operation
Secondary Rates of (a) intra-operative, (b) early post-operative (within 30 days of operation) and (c) late post-operative complications. Early and late complications will be grouped into local wound complications (e.g. wound infection, seroma etc) and systemic complications (e.g. pneumonia, myocardial infarction etc). We will follow the Clavien-Dindo classification scheme. Up to 3 years after the patients operation.
Secondary Ventral hernia recurrence Rate of ventral hernia recurrence at 3 years, defined by clinical examination and supplemented by cross-sectional imaging where there is diagnostic uncertainty. Recurrence will be defined using the European classification for ventral hernia recurrence. At 3 year after the patients operation.
See also
  Status Clinical Trial Phase
Recruiting NCT06016426 - Mass Closure vs Layer by Layer Closure N/A
Recruiting NCT05572021 - A Comparison of the Outcomes in Fortiva and Strattice Mesh N/A
Completed NCT02263599 - Conservative Treatment For Ventral Hernia
Completed NCT02263625 - Regional Differences In Indication for Ventral Hernia Repair
Completed NCT02292264 - Risk Factors and Complications of Ventral Hernia Repair
Completed NCT01961687 - A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair. N/A
Completed NCT01325246 - Reoperation Rate Versus Clinical Recurrence After Ventral Hernia Repair N/A
Completed NCT03283982 - Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM N/A
Not yet recruiting NCT05526209 - Longitudinal Relaxing Incision as a Technique for Recurrence Prevention in Ventral Hernia
Completed NCT04438369 - Evaluation of Ultrasound-guided Erector Spinae Block for Postoperative Analgesia in Laprascopic Ventral Hernia Repair. N/A
Recruiting NCT04173884 - Video-based Collaborative Learning to Improve Ventral Hernia Repair N/A
Recruiting NCT02703662 - Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction Phase 2/Phase 3
Completed NCT03938688 - Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation N/A
Completed NCT01719718 - The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair N/A
Completed NCT03342040 - Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair N/A
Completed NCT04150796 - Comparing eTEP and Laparoscopic Intraperitoneal Onlay Mesh (IPOM) for Ventral Hernias N/A
Recruiting NCT03222102 - Ventral Hernia Prevention After Liver Transplantation N/A
Completed NCT05610267 - Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair
Terminated NCT01794338 - The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients N/A
Completed NCT01886963 - A Clinical Trial Using Spy Elite System in Planning Tissue Advancement Flaps After Ventral Hernia Repair N/A